Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Lippuner

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 30, 2014
The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT)Dennis M Black, Ian R Reid, Jane A Cauley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 31, 2006
Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or =70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF studyMarc-Antoine Krieg, Jacques Cornuz, Christiane Ruffieux, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 14, 2011
The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)Dennis M Black, Ian R Reid, Steven Boonen, et al.
The New England Journal of Medicine|November 2, 2012
Fracture risk and zoledronic acid therapy in men with osteoporosisSteven Boonen, Jean-Yves Reginster, Jean-Marc Kaufman, et al.
The Lancet. Diabetes & Endocrinology|May 27, 2017
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extensionHenry G Bone, Rachel B Wagman, Maria L Brandi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 27, 2015
A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAXEugene V McCloskey, Anders Odén, Nicholas C Harvey, et al.
The Lancet. Diabetes & Endocrinology|November 3, 2019
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension studyMichael R McClung, Michelle L O'Donoghue, Socrates E Papapoulos, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 13, 2026
Predictive value of BMD for hip and other fractures: a meta-analysis to update FRAXJohn A Kanis, Eugene V McCloskey, Helena Johansson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 16, 2024
A meta-analysis of previous falls and subsequent fracture risk in cohort studiesLiesbeth Vandenput, Helena Johansson, Eugene V McCloskey, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 23, 2025
Family history of fracture and fracture risk: a meta-analysis to update the FRAX® risk assessment toolEugene V McCloskey, Helena Johansson, Enwu Liu, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 30, 2014
The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT)Dennis M Black, Ian R Reid, Jane A Cauley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 31, 2006
Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or =70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF studyMarc-Antoine Krieg, Jacques Cornuz, Christiane Ruffieux, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 14, 2011
The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)Dennis M Black, Ian R Reid, Steven Boonen, et al.
The New England Journal of Medicine|November 2, 2012
Fracture risk and zoledronic acid therapy in men with osteoporosisSteven Boonen, Jean-Yves Reginster, Jean-Marc Kaufman, et al.
The Lancet. Diabetes & Endocrinology|May 27, 2017
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extensionHenry G Bone, Rachel B Wagman, Maria L Brandi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 27, 2015
A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAXEugene V McCloskey, Anders Odén, Nicholas C Harvey, et al.
The Lancet. Diabetes & Endocrinology|November 3, 2019
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension studyMichael R McClung, Michelle L O'Donoghue, Socrates E Papapoulos, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 13, 2026
Predictive value of BMD for hip and other fractures: a meta-analysis to update FRAXJohn A Kanis, Eugene V McCloskey, Helena Johansson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 16, 2024
A meta-analysis of previous falls and subsequent fracture risk in cohort studiesLiesbeth Vandenput, Helena Johansson, Eugene V McCloskey, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 23, 2025
Family history of fracture and fracture risk: a meta-analysis to update the FRAX® risk assessment toolEugene V McCloskey, Helena Johansson, Enwu Liu, et al.
Pageof 9